Results 161 to 170 of about 2,244 (195)

In Brief: A New Torsemide Formulation (Soaanz) for Edema

The Medical Letter on Drugs and Therapeutics
The FDA has approved Soaanz (Sarfez), a new formulation of the loop diuretic torsemide, for treatment of edema associated with heart failure or renal disease in adults. Torsemide has been available generically for years for treatment of hypertension and treatment of edema due to heart failure, renal disease, or hepatic disease.
openaire   +2 more sources

Torsemide as a Primary Choice in Edema Associated with Heart Failure

Journal of The Association of Physicians of India
Heart failure (HF) is the fastest-growing disease with a higher fatality rate. The most differentiating feature of HF is pulmonary or peripheral edema, which is characterized by a gradient between intravascular and extravascular pressure. Loop diuretics were chosen as the primary treatment for edema associated with HF due to their efficacy and early ...
Janakiraman, Ezhilan, Sunil, Dighe, Chetan, Shah, Mangesh, Tiwaskar, Vikas, Chopra, Rahul, Patil, Prabin, Srivastava, Asha, Mahilmaran, Akshyaya, Pradhan, Suzaur, Rahman, Amit, Malviya, Anshuman, Gupta, Phani, Teja, Febin, Francis, Amarnath, Sugumaran   +14 more
openaire   +2 more sources

Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial

Circulation, 2023
Stephen J Greene, Robert J Mentz, Andrew P. Ambrosy   +2 more
exaly  

Torsemide

Reactions Weekly, 1997
openaire   +1 more source

Torsemide-Induced Pseudoporphyria

Archives of Dermatology, 2008
Alicia Pérez-Bustillo, Pedro Sánchez-Sambucety, Óscar Suárez-Amor, Manuel Angel Rodríiguez-Prieto   +3 more
openaire   +1 more source

Torsemide

2012
William G. Cioffi, Michael D. Connolly, Charles A. Adams, Mechem C. Crawford, Aaron Richman, William H. Shoff, Catherine T. Shoff, Suzanne M. Shepherd, Benjamin S. Abella, Thomas H. Cogbill, Stefan De Hert, Christiaan Keijzer, Toby M. Enniss, J. Wayne Meredith, Sacha Zeerleder, Sacha Zeerleder, Kenneth L. Mattox, Frederick Fiesseler, Richard D. Shih, Marina S. Morgan, Edmund Ong, Nikhil Premchand, Gregory W. Fischer, Edmond Cohen, Robert S. Green, Donald Griesdale, Christian Byhahn, Charles G. Durbin, Gregory J. Jurkovich, Marcus J. Schultz, Ognjen Gajic, Richard J. Mullins, Christian A. Hamlat, Ronald V. Maier, Christian A. Hamlat, Ronald V. Maier, E. Mark Hammerberg, Raeanna C. Adams, Oliver L. Gunter, John A. Morris, David K. Menon, Jordan Bonomo, Edgardo S. Salcedo, Jose L. Pascual, Philip F. Stahel, Michael A. Flierl, Brittany Matava, David C. Cone, Rui P. Moreno, Susan M. Lareau, Richard H. Beigi, Stefan Herget-Rosenthal, Keri A. Cohn, Sarah L. Wingerter, Lise E. Nigrovic   +54 more
openaire   +1 more source

An evaluation of torsemide in patients with heart failure and renal disease

Expert Review of Cardiovascular Therapy, 2022
Stephen J Greene, Robert J Mentz, Anthony E Peters   +2 more
exaly  

Stability of torsemide in 5% dextrose injection

American Journal of Health-System Pharmacy, 1998
P A, Montgomery, L A, Cornish, C E, Johnson, K A, Fitzpatrick   +3 more
openaire   +2 more sources

Torsemide increases arsenic concentrations by inhibition of multidrug resistance protein 4 in arsenic trioxide treated acute promyelocytic leukemia patients

Biomedicine and Pharmacotherapy, 2023
Xin Hai
exaly  

Torsemide Tablets

2021
openaire   +1 more source